Skip to main content
Livermore
Livermore
ZHEN

Dodge & Cox

SEC CIK
0000200217
Latest filing
Aug 13, 2026

ALNY holding history

Alnylam Pharmaceuticals, Inc. in every 13F filed by Dodge & Cox, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ALNY overviewAll 13F holders of ALNYFull Q2 2026 holdings

Shares (Q2 2026)
1,955,393
Value
$588.6M
% of portfolio
0.3%
Quarters held
22
Since Q1 2021
Holdings of ALNY by Dodge & Cox, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,955,393$588.6M0.3%+26,140+1.4%AddedHolders
Q1 20261,929,253$638.3M0.4%−35,162−1.8%ReducedHolders
Q4 20251,964,415$781.1M0.4%−356,815−15.4%ReducedHolders
Q3 20252,321,230$1.06B0.6%−875,866−27.4%ReducedHolders
Q2 20253,197,096$1.04B0.6%−154,666−4.6%ReducedHolders
Q1 20253,351,762$905.0M0.5%−188,500−5.3%ReducedHolders
Q4 20243,540,262$833.1M0.5%−82,273−2.3%ReducedHolders
Q3 20243,622,535$996.3M0.6%−157,650−4.2%ReducedHolders
Q2 20243,780,185$918.6M0.6%−31,295−0.8%ReducedHolders
Q1 20243,811,480$569.6M0.3%+137,170+3.7%AddedHolders
Q4 20233,674,310$703.3M0.4%−72,845−1.9%ReducedHolders
Q3 20233,747,155$663.6M0.4%−42,370−1.1%ReducedHolders
Q2 20233,789,525$719.8M0.5%−105,010−2.7%ReducedHolders
Q1 20233,894,535$780.2M0.5%−696,247−15.2%ReducedHolders
Q4 20224,590,782$1.09B0.7%−298,515−6.1%ReducedHolders
Q3 20224,889,297$978.6M0.7%−369,659−7.0%ReducedHolders
Q2 20225,258,956$767.0M0.5%−216,712−4.0%ReducedHolders
Q1 20225,475,668$894.1M0.5%+44,600+0.8%AddedHolders
Q4 20215,431,068$921.0M0.6%+58,968+1.1%AddedHolders
Q3 20215,372,100$1.01B0.7%−41,901−0.8%ReducedHolders
Q2 20215,414,001$917.8M0.6%+1,092,374+25.3%AddedHolders
Q1 20214,321,627$610.2M0.4%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.